| NCT ID | NCT05782556 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Freiburg |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2033-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-01-01 with a primary completion date of 2033-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial. Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 months after TIPS implantation following a regular follow-up schedule with clinical visits at the University Medical Center Freiburg. During follow-up visits, serum/plasma samples and peripheral blood mononuclear cells (PBMC) are collected and stored in a associated biobank.
Eligibility Criteria
Inclusion Criteria: * Patients allocated to TIPS implantation due to clinically significant cirrhotic and non-cirrhotic portal hypertension Exclusion Criteria: * Withdrawal of written informed consent
Contact & Investigator
Dominik Bettinger, MD
PRINCIPAL INVESTIGATOR
University Hospital Freiburg
Frequently Asked Questions
Who can join the NCT05782556 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05782556 currently recruiting?
Yes, NCT05782556 is actively recruiting participants. Contact the research team at dominik.bettinger@uniklinik-freiburg.de for enrollment information.
Where is the NCT05782556 trial being conducted?
This trial is being conducted at Freiburg im Breisgau, Germany.
Who is sponsoring the NCT05782556 clinical trial?
NCT05782556 is sponsored by University Hospital Freiburg. The principal investigator is Dominik Bettinger, MD at University Hospital Freiburg. The trial plans to enroll 2,000 participants.